Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating ASP-1929 photoimmunotherapy in combination with cemiplimab for refractory, inoperable, and metastatic non-small cel…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer [Phase 1]
A Phase 1 study of PF-07921585 alone or with other anti-cancer medicines in multiple cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Multiparametric PET-MRI Integration for a New Approach to Tumor Heterogeneity in Non-Small Cell Lung Cancer (NSCLC): Pilot Study [NA]
This clinical trial evaluated multiparametric PET-MRI to study tumor heterogeneity in non-small cell lung cancer, but the pilot study has be…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion [Phase 2]
Phase 2 clinical trial evaluating furmonertinib plus radiotherapy for EGFR-positive non-small cell lung cancer with malignant pleural effusi…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
The NOTION study investigates in-home sampling of cytokines in cancer patients receiving immunotherapy, and the trial has completed. The con…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Liquid Biopsy Monitoring Of EGFR T790M in Advanced Non-Small Cell Lung Cancer
Clinical trial update describing liquid biopsy monitoring of EGFR T790M in advanced Non-Small Cell Lung Cancer. The study status is complete…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR) [Phase 3]
Phase 3 trial update on Tumor Treating Fields (TTFields) at 150 kHz used alongside standard therapies for stage IV non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases [Phase 1, Phase 2]
A Phase 1/2 trial evaluating Bintrafusp alfa in combination with Pimasertib for brain metastases has been terminated, with results posted in…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies [Phase 1, Phase 2]
Phase 1/2 trial of plinabulin with radiation and immunotherapy in select advanced cancers after progression on PD-1/PD-L1 therapy was termin…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
A Phase 3 trial compares the efficacy and safety of adding a new treatment to tislelizumab in non-small cell lung cancer. The study is curre…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: A Study to Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation in Participants With Locally Advanced Unresectable Non-Small Cell Lung Cancer (LADOGA) [Phase 2]
This clinical trial update reports a Phase 2 study (LADOGA) evaluating durvalumab with oleclumab after chemoradiation in locally advanced un…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 [Phase 2, Phase 3]
Ongoing Phase 2 and Phase 3 trials from Mirati evaluate adagrasib as a standalone therapy and in combination with pembrolizumab for KRAS G12…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation [Phase 1]
AstraZeneca's Phase I/IIa study of AZD0022 in KRASG12D-mutant tumors has been terminated. The study enrolled adults with advanced solid tumo…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases [Phase 2]
Phase 2 trial evaluating osimertinib with or without bevacizumab in EGFR-positive non-small cell lung cancer with brain metastases; results …
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence [EARLY_Phase 1]
An early-phase Phase 1 trial of CIMAvax-EGF for prevention of lung cancer development or recurrence has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation [NA]
The clinical trial update evaluates the correlation between tissue and plasma EGFR status in non-small cell lung cancer with EGFR mutation o…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors [Phase 2]
Phase 2 trial of brentuximab vedotin in combination with pembrolizumab for metastatic solid tumors has completed, enrolling patients with me…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung Cancer [Phase 1]
A Phase 1 study evaluating ONO-7475 in combination with osimertinib for EGFR mutation-positive non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers [NA]
This entry notes the completion of a clinical trial studying the expression of Met receptor fragments in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung Cancer [Phase 1, Phase 2]
A clinical trial update describing a Phase 1/2 study of the combination of amivantamab and cetrelimab in participants with metastatic non-sm…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Cohort of Non-small Cell Lung Cancer With Mutation of the Nord Pas de Calais (CB(NPC)²)
This document reports a completed clinical trial update for a cohort of non-small cell lung cancer patients with the CB(NPC)² mutation, spon…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Compare Bevacizumab in Combination With Erlotinib Versus Erlotinib Alone in NSCLC Patients Activating EGFR Mutations [Phase 3]
Phase 3 trial comparing bevacizumab plus erlotinib versus erlotinib alone in non-small cell lung cancer with activating EGFR mutations has c…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Ascorbate With Durvalumab in Non-Small Cell Lung Cancer (NSCLC) [Phase 1]
Phase 1 clinical trial evaluating ascorbate in combination with durvalumab for non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: A Study of SKB264 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating SKB264 in combination with pembrolizumab versus pembrolizumab alone for locally advanced or metastatic Non-Small …
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer
A clinical trial update exploring the mechanism behind enhanced efficacy of Ivonescimab when used in neoadjuvant therapy for non-small cell …